BOLD
Boundless Bio, Inc.
Next earnings Aug 3, 2026 · consensus $-0.61 EPS
Last earnings -5.9% on 2026-05-08
$2.51
▼ -3.46%$2.51▲ +141.35%
over 1Y
L $1.01EODHDH $2.60
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-3.5%
1W+85.7%
1M+76.9%
3M+130.1%
YTD+113.1%
1Y+150.0%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Sell
Conservative balance sheet (liabilities/equity 0.59x).
Boundless Bio, Inc. shows limited reported revenue, and -59.0% ROE.
Sources: SEC EDGAR (CIK 0001782303, latest 10-Q filed 2026-05-08) · EODHD · as of 6/25/2026, 10:44:16 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.